Photobiomodulation Therapy for Chemotherapy Hair Loss
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 72 (estimated)
- Sponsor
- Jessa Hospital · Other
This trial is looking for patients with gynecological or breast cancer who are experiencing hair loss due to chemotherapy. Participants will receive a specific light therapy to help manage this hair loss.
You may be able to join if
- I have been diagnosed with gynecological cancer or breast cancer.
- I am receiving chemotherapy.
- I am 18 years or older.
- I can follow the study instructions.
- I can sign a written consent form.
You may not be able to join if
- I have metastatic cancer.
- I am pregnant.
- I currently have an infection on my scalp.
- I have been diagnosed with a hair loss condition before.
- My chemotherapy has been interrupted for more than two cycles.
- I take medication to promote hair growth.
- I have a severe psychological disorder or dementia.
- I cannot speak or understand Dutch.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the prevention and management of chemotherapy-induced alopecia (CIA). Therefore, we hypothesize that PBMT can reduce the severity of CIA in gynecological and breast cancer patients, increasing the patient's QoL.
Loading trial locations…